From Yahoo Finance: 2025-04-03 08:45:00

Zoetis (NYSE: ZTS) stands out as a top dividend stock for income investors with a strong business model. The animal health leader consistently raises dividends and boasts a diverse product lineup generating $9.3 billion in revenue in 2024. Despite recent setbacks, Zoetis remains poised for long-term growth.

While Zoetis faces challenges in 2025 due to new competition, the company’s track record and prospects are impressive. With products like Solensia and Librela contributing to sales, Zoetis is well-positioned for continued success. The company’s focus on the humanization of pets and its companion animal unit drive growth opportunities.

Zoetis has increased dividends by 502% since its IPO in 2013, showcasing its commitment to rewarding shareholders. Despite a current forward yield of 1.2%, below the S&P 500 average, Zoetis’ track record and cash payout ratio of 34% indicate potential for future payout increases. Consider Zoetis as a top income stock for long-term investment.

Read more: This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years